Background Estimates of the case hospitalization rate and case fatality rate when hospital
care is available for monkeypox (MPX) infections have not been well defined. This rapid …

Bispecific T cell engagers (BiTEs) are an innovative class of immunotherapeutics that
redirect T cells to tumor surface antigens. While efficacious against certain hematological …

Background and Objective: The recent multi-country outbreak of human monkeypox (HMPX)
in non-endemic regions poses an emerging public health concern. University students in …

The neglected and rare zoonotic disease caused by monkeypox virus (MPV) has recently
spread widely, resulting in the largest known monkeypox outbreak outside of Africa, where it …

Breakthrough Infections after Postexposure Vaccination against Mpox | New England Journal
of Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

The ongoing multi-country human monkeypox (HMPX) outbreak was declared as a public
health emergency of international concern. Considering the key role of healthcare workers …

Host pattern recognition receptors (PRRs) sense pathogen-associated molecular patterns
(PAMPs), which are molecular signatures shared by different pathogens. Recognition of …

Mpox—formerly monkeypox—is a re-emerging zoonotic virus disease, with large numbers of
human cases reported during multi-country outbreaks in 2022. The close similarities in …

Monkeypox is a self-limiting zoonotic viral disease and causes smallpox-like symptoms. The
disease has a case fatality ratio of 3–6% and, recently, a multi-country outbreak of the …

In the last five years, the prevalence of monkeypox has been increasing both in the regions
considered endemic for the disease (West and Central Africa) and worldwide. Indeed, in …